IP Verse

Antibody Producing Non-Human Mammals - EP3456190

The patent EP3456190 was granted to Merus on Nov 24, 2021. The application was originally filed on Jun 29, 2009 under application number EP18183980A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3456190

MERUS
Application Number
EP18183980A
Filing Date
Jun 29, 2009
Status
Granted And Under Opposition
Oct 22, 2021
Grant Date
Nov 24, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KYMABAug 19, 2022CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE

Patent Citations (22) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0469025
DESCRIPTIONEP1439234
DESCRIPTIONWO2004106375
DESCRIPTIONWO2005068622
DESCRIPTIONWO9852976
OPPOSITIONEP1439234
OPPOSITIONUS2006015957
OPPOSITIONUS2007280945
OPPOSITIONUS2016238600
OPPOSITIONWO02066630
OPPOSITIONWO2004009618
OPPOSITIONWO2004106375
OPPOSITIONWO2006117699
OPPOSITIONWO2008054606
OPPOSITIONWO2008076379
OPPOSITIONWO9850431
SEARCHEP0814159
SEARCHEP1439234
SEARCHWO02066630
SEARCHWO2004106375
SEARCHWO2005068622
SEARCHWO2006117699

Non-Patent Literature (NPL) Citations (97) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALMAGRO, J. C. et al., Frontiers in Bioscience, (20080000), vol. 13, page 1619-
DESCRIPTION- BRADY et al., JIM, (20060000), vol. 315, page 61-
DESCRIPTION- CARTER, P. et al., Proc. Natl. Acad. Sci. U. S. A., (19920000), vol. 89, page 4285-
DESCRIPTION- DECHIARA et al., Methods Mol Biol, (20090000), vol. 530, pages 311 - 324-
DESCRIPTION- DE KRUIF et al., J. Mol. Biol., (20090000), vol. 387, page 548-
DESCRIPTION- DESMET et al., FASEB J., (19970000), vol. 11, pages 164 - 172-
DESCRIPTION- DESMET et al., Nature, (19920000), vol. 356, pages 539 - 542-
DESCRIPTION- DESMET et al., Proteins, (20020000), vol. 48, pages 31 - 43-
DESCRIPTION- DESMET et al., Proteins, (20050000), vol. 58, pages 53 - 69-
DESCRIPTION- DE WILDT et al., J. Mol. Biol., (19990000), vol. 285, no. 3, page 895-
DESCRIPTION- EGGAN et al., PNAS, vol. 98, pages 6209 - 6214-
DESCRIPTION- EWERT et al., J. Mol. Biol., (20030000), vol. 325, no. 3, page 531-
DESCRIPTION- GASCAN et al., J. Exp. Med., (19910000), vol. 173, pages 747 - 750-
DESCRIPTION- GREEN et al., Nat Genet, (19940000), vol. 7, pages 13 - 21-
DESCRIPTION- HOOGENBOOM, H. R. et al., Nat. Biotechnol., (20050000), vol. 23, page 1105-
DESCRIPTION- HWANG, W. Y. et al., Methods, (20050000), vol. 36, no. 1, pages 3 - 10-
DESCRIPTION- HWANG, W. Y. et al., th, (20050000), vol. 36, page 3-
DESCRIPTION- IGNATOVICH,O.; TOMLINSON,I.M.; POPOV,A.V.; BRUGGEMANN,M.; WINTER,G., J. Mol. Biol., (19990000), vol. 294, no. 2, pages 457 - 465-
DESCRIPTION- INLAY, M. et al., Nat. Immunol., (20020000), vol. 3, page 463-
DESCRIPTION- JAIN, M. et al., Trends in Biotechnol., (20070000), vol. 25, page 307-
DESCRIPTION- JAKOBOVITS, A. et al., Nat. Biotechnol., (20070000), vol. 25, page 1134-
DESCRIPTION- JONES, P.T. et al., Nature, (19860000), vol. 321, page 522-
DESCRIPTION- KRAMER et al., Nucleic Acids Res., (20030000), vol. 31, no. 11, page e59-
DESCRIPTION- KWAKS et al., Trends Biotechnol., (20060000), vol. 24, no. 3, pages 137 - 142-
DESCRIPTION- LAZAR, G. A. et al., Mol. Immunol., (20070000), vol. 44, page 1986-
DESCRIPTION- LOFGREN, J. A. et al., J. Immunol., (20070000), vol. 178, page 7467-
DESCRIPTION- LONBERG et al., Nature, (19940000), vol. 368, pages 856 - 859-
DESCRIPTION- LONBERG, N., Nat. Biotechnol., (20050000), vol. 23, page 1117-
DESCRIPTION- MEYER et al., Int. Immunol., (19960000), vol. 8, page 1561-
DESCRIPTION- MEYER, K. B. et al., Nucleic Acids Res., (19900000), vol. 18, no. 19, pages 5609 - 5615-
DESCRIPTION- MIDDENDORP et al., J. Immunol., (20020000), vol. 168, page 2695-
DESCRIPTION- MIDDENDORP et al., J. Immunol., (20040000), vol. 172, page 1371-
DESCRIPTION- MIN-SOO KIM et al., JMB, (20070000), vol. 374, pages 1374 - 1388-
DESCRIPTION- MIRICK et al., Q. Nucl. Med. Mol. Imaging, (20040000), vol. 48, pages 251 - 257-
DESCRIPTION- MORRISON, S. L. et al., Proc. Natl. Acad. Sci. USA., (19840000), vol. 81, pages 6851 - 6855-
DESCRIPTION- NAOKO et al., Can. Res., (20070000), vol. 67, pages 817 - 875-
DESCRIPTION- ODEGARD, V. H. et al., Nat. Rev. Immunol., (20060000), vol. 6, page 573-
DESCRIPTION- PADLAN, E. A. et al., Mol. Immunol., (19910000), vol. 28, page 489-
DESCRIPTION- Protein, Database accession no. AAF20450, URL: ncbi-
DESCRIPTION- Protein, Database accession no. ABA26122, URL: ncbi-
DESCRIPTION- QUEEN, C. et al., Proc. Natl. Acad. Sci. U. S. A., (19890000), vol. 86, page 10029-
DESCRIPTION- RAJEWSKY et al., J. Clin. Invest., (19960000), vol. 98, pages 600 - 603-
DESCRIPTION- SEIBLER J et al., Nucleic Acids Res., (20030215), vol. 31, no. 4, page e12-
DESCRIPTION- SEIBLER J; ZEVNIK B; KIITER-LUKS B; ANDREAS S; KERN H; HENNEK T; RODE A; HEIMANNC; FAUST N; KAUSELMANN G, Nucleic Acids Res., (20030215), vol. 31, no. 4, page e12-
DESCRIPTION- SHVARTS et al., Genes Dev, (20020000), vol. 16, pages 681 - 686-
DESCRIPTION- "Summary of mouse development", HOGAN et al., Manipulating the Mouse Embryo, Cold Spring Harbor Laboratory Press, (19940000), pages 253 - 289-
DESCRIPTION- TAN, P., D. A. et al., J. Immunol., (20020000), vol. 169, page 1119-
DESCRIPTION- TAYLOR et al., Nucleic Acids Res, (19920000), vol. 20, pages 6287 - 6295-
DESCRIPTION- THIEBE et al., European Journal of Immunology, (19990000), vol. 29, pages 2072 - 2081-
DESCRIPTION- THROSBY, M., J Virol, (20060000), vol. 80, pages 6982 - 6992-
DESCRIPTION- WINTER, G. et al., Annu. Rev. Immunol., (19940000), vol. 12, page 433-
DESCRIPTION- WUNDERLICH F. T., "Generation of inducible Cre systems for conditional gene inactivation in mice", Inauguraldissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultat der Universitat zu Koln, (20040000), URL: http://deposit.ddb.de/cgi-bin/dok erv?idn= 97557230x&dok_var=d1&dok_ext=pdf&filename=97567230x.pdf-
DESCRIPTION- WUNDERLICH F. T., "Generation of inducible Cre systems for conditional gene inactivation in mice", Inauguraldissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultat der Universitat zu Koln, (20040000), URL: http://deposit.ddb.de/cgi-bin/dokserv?idn=97557230x&dok_var=d 1 &dok_ext=pdf&file name=9755723 Ox.pd-
EXAMINATION- Horwitz David A ET AL, "Distinctive Functional Properties of Human Blood L Lymphocytes: A Comparison with T Lymphocytes, B Lymphocytes, and Monocytes", The Journal of immunology (1950), United States, (19770501), pages 1712 - 1721, URL: https://www.jimmunol.org/content/jimmunol/118/5/1712.full.pdf, (20210622), XP055816820-
EXAMINATION- JUDDE J-G ET AL, "Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, (19921101), vol. 12, no. 11, ISSN 0270-7306, pages 5206 - 5216, XP001069601-
EXAMINATION- WOODLEY L ET AL, "REGULATION OF ALTERNATIVE PRE-MRNA SPLICING", BRIEFINGS IN FUNCTIONAL GENOMICS AND PROTEOMICS, HENRY STEWART, LONDON, GB, (20021001), vol. 1, no. 3, ISSN 1473-9550, pages 266 - 277, XP001168605-
EXAMINATION- Ivan J. Fuss ET AL, "Isolation of Whole Mononuclear Cells from Peripheral Blood and Cord Blood", Current Protocols in Immunology, Hoboken, NJ, USA, John Wiley & Sons, Inc., (20010501), doi:10.1002/0471142735.im0701s85, ISBN 978-0-47-114273-7, XP055072167
EXAMINATION- FALKOFF R M ET AL, "T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 50, no. 1, doi:10.1016/0022-1759(82)90302-7, ISSN 0022-1759, (19820416), pages 39 - 49, (19820416), XP023676462
EXAMINATION- BETZ A G ET AL, "Elements regulating somatic hypermutation of an immunoglobulin @k gene: Critical role for the intron enhancer/matrix attachment region", CELL, ELSEVIER, AMSTERDAM NL, vol. 77, no. 2, doi:10.1016/0092-8674(94)90316-6, ISSN 0092-8674, (19940422), pages 239 - 248, (19940422), XP024245265
EXAMINATION- LARRICK J W ET AL, "Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM NL, (19890515), vol. 160, no. 3, doi:10.1016/S0006-291X(89)80138-X, ISSN 0006-291X, pages 1250 - 1256, XP000293053
EXAMINATION- GOODNOW CHRISTOPHER C ET AL, "Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice", NATURE, MACMILLAN JOURNALS LTD., ETC, LONDON, vol. 334, no. 6184, doi:10.1038/334676A0, ISSN 0028-0836, (19880801), pages 676 - 682, (19880801), XP037103628
EXAMINATION- CARTEGNI L ET AL, "Listening to silence and understanding nonsense: exonic mutations that affect splicing", NATURE REVIEWS GENETICS, MACMILLAN MAGAZINES, GB, (20020401), vol. 3, no. 4, doi:10.1038/NRG775, pages 285 - 298, XP002262849
EXAMINATION- KERSTIN B MEYER ET AL, "The importance of the 3'-enhancer region in immunoglobulin x gene expression", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, (19901011), vol. 18, no. 19, doi:10.1093/NAR/18.19.5609, ISSN 0305-1048, pages 5609 - 5615, XP001525496
EXAMINATION- FAUSTINO N. A. ET AL, "Pre-mRNA splicing and human disease", GENES & DEVELOPMENT, vol. 17, no. 4, doi:10.1101/gad.1048803, (20030215), pages 419 - 437, URL: http://genesdev.cshlp.org/content/17/4/419.full.pdf, XP055816814
EXAMINATION- L M Carlson ET AL, "Templated insertions in the rearranged chicken IgL V gene segment arise by intrachromosomal gene conversion.", GENES AND DEVELOPMENT., US, (19900401), vol. 4, no. 4, doi:10.1101/gad.4.4.536, ISSN 0890-9369, pages 536 - 547, XP055654273
EXAMINATION- FATHIMA SHAMILA ET AL, "Comparison of Manual Versus Automated Data Collection Method for Haematological Parameters", BIOMEDICAL JOURNAL OF SCIENTIFIC & TECHNICAL RESEARCH, vol. 15, no. 3, doi:10.26717/BJSTR.2019.15.002702, (20190301), URL: https://biomedres.us/pdfs/BJSTR.MS.ID.002702.pdf, XP055816823
OPPOSITION- AUCOUTURIER P. et al., "Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome", The Journal of Immunology, US , (19930415), vol. 150, no. 8, ISSN 0022-1767, pages 3561 - 3568, XP003030515-
OPPOSITION- "Chapter 8 - The Development and Survival of Lymphocytes", Murphy Kenneth, et al., Janeway's Immunobiology, 8th ed., (20110101), pages 275 - 290, ISBN 978-0-8153-4243-4, XP055959299-
OPPOSITION- "Human rearranged lgK mRNA VJC region", Nucleotide, NCBI, (19941028), Database accession no. M87478, XP003030516-
OPPOSITION- "immunoglobulin light chain variable region, partial [Homo sapiens] ", Protein, NCBI, (20051231), Database accession no. ABA26122, XP055959312-
OPPOSITION- Janeway, Jr. Charles A., Travers Paul, Walport Mark, Capra J. Donald, Immunobiology - the Immune System in Health and Disease, 4th ed., (19990101), pages 90 - 108, XP055959330-
OPPOSITION- Mike Nagle, "Regeneron helps make Sanofi Velocimmune to its 'weak' pipeline", Outsourcing - Pharma.com, (20071203), URL: http://www.outsourcing-pharma.com/content/view/print/325803, XP055512949-
OPPOSITION- Sirac Christophe, Bridoux F., Essig M., Devuyst O., Touchard G., Cogné M., "Toward Understanding Renal Fanconi Syndrome: Step by Step Advances through Experimental Models", Experimental Models for Renal Diseases: Pathogenesis and Diagnosis, (20110101), vol. 169, pages 247 - 261, XP055959324-
OPPOSITION- STEVEN S., "HUMAN ANTIBODY DISCOVERY, VELOCIMMUNE - A NOVEL PLATFORM", Pharma Focus Asia, Thailand , (20080101), no. 8, ISSN 0044-9164, pages 72 - 74, XP003035153-
OPPOSITION- Torres Raul M., Ralf Kuhn, Laboratory Protocols for Conditional Gene targeting, Oxford University Press , (19970101), pages 42 - 53, ISBN 978-0-19-963677-8, XP055959290-
OPPOSITION- de Wildt, R.M.T. Hoet, R.M.A. van Venrooij, W.J. Tomlinson, I.M. Winter, G., "Analysis of Heavy and Light Chain Pairings Indicates that Receptor Editing Shapes the Human Antibody Repertoire", Journal of Molecular Biology, United Kingdom , (19990122), vol. 285, no. 3, doi:10.1006/jmbi.1998.2396, ISSN 0022-2836, pages 895 - 901, XP004449605
OPPOSITION- Dechiara T M; Poueymirou W T; Auerbach W; Frendewey D; Yancopoulos G D; Valenzuela D M, "Chapter 16 - VelociMouse: Fully ES Cell-Derived F0-Generation Mice Obtained from the Injection of ES Cells into Eight-Cell-Stage Embryos", Dechiara T M; Poueymirou W T; Auerbach W; Frendewey D; Yancopoulos G D; Valenzuela D M, Kuhn et al., GENE KNOCKOUT PROTOCOLS, 2nd ed., (20090101), vol. 530, pages 311 - 324, doi:10.1007/978-1-59745-471-1_16, ISBN 978-1-62703-541-5, XP008113126
OPPOSITION- Sasaki Yoshiteru; Derudder Emmanuel; Hobeika Elias; Pelanda Roberta; Reth Michael; Rajewsky Klaus; Schmidt-Supprian Marc, "Canonical NF-kB Activity, Dispensable for B Cell Development, Replaces BAFF-Receptor Signals and Promotes B Cell Proliferation upon Activation", Immunity, AMSTERDAM, NL , (20060601), vol. 24, no. 6, doi:10.1016/j.immuni.2006.04.005, ISSN 1074-7613, pages 729 - 739, XP086676568
OPPOSITION- Logtenberg, T., "Antibody cocktails: next-generation biopharmaceuticals with improved potency", TRENDS IN BIOTECHNOLOGY, GB , (20070823), vol. 25, no. 9, doi:10.1016/j.tibtech.2007.07.005, ISSN 0167-7799, pages 390 - 394, XP022210238
OPPOSITION- CARTER PAUL, "Bispecific human IgG by design", Journal of Immunological Methods, NL , (20010101), vol. 248, no. 1-2, doi:10.1016/S0022-1759(00)00339-2, ISSN 0022-1759, pages 7 - 15, XP002974199
OPPOSITION- Nature Biotechnology, (20070601), vol. 25, no. 6, doi:10.1038/nbt0607-613, ISSN 1087-0156, pages 613 - 614, XP037923851
OPPOSITION- SCOTT C.T., "MICE WITH A HUMAN TOUCH", Nature Biotechnology, New York, (20071001), vol. 25, no. 10, doi:10.1038/nbt1007-1075, ISSN 1087-0156, pages 1075 - 1077, XP003035613
OPPOSITION- Nemazee David, "Receptor editing in lymphocyte development and central tolerance", Nature Reviews Immunology, London, (20061001), vol. 6, no. 10, doi:10.1038/nri1939, ISSN 1474-1733, pages 728 - 740, XP055959278
OPPOSITION- C. Sirac, C. Carrion, S. Duchez, I. Comte, M. Cogne, "Light chain inclusion permits terminal B cell differentiation and does not necessarily result in autoreactivity", Proceedings of the National Academy of Sciences, (20060516), vol. 103, no. 20, doi:10.1073/pnas.0509121103, ISSN 0027-8424, pages 7747 - 7752, XP055368772
OPPOSITION- POPOV A. V. et al., "A HUMAN IMMUNOGLOBULIN L LOCUS IS SIMILARLY WELL EXPRESSED IN MICE AND HUMANS.", Journal of Experimental Medicine, US , (19990517), vol. 189., no. 10., doi:10.1084/jem.189.10.1611, ISSN 0022-1007, pages 1611 - 1620, XP000891331
OPPOSITION- Rickert Robert C., Roes Jürgen, Rajewsky Klaus, "B lymphocyte-specific, Cre-mediated mutagenesis in mice", Nucleic Acids Research, (19970315), vol. 25, no. 6, doi:10.1093/nar/25.6.1317, pages 1317 - 1318, XP055959275
OPPOSITION- Lefranc M P, "Nomenclature of the human immunoglobulin kappa (IGK) genes", EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, CH , (20010101), vol. 18, no. 3, doi:10.1159/000049195, ISSN 0254-9670, pages 161 - 174, XP009096781
OPPOSITION- SIRAC C. et al., "Role of the monoclonal k chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome", Blood, US , (20060715), vol. 108, no. 2, doi:10.1182/blood-2005-11-4419, ISSN 0006-4971, pages 536 - 543, XP003030514
OPPOSITION- Andrew T. Hutchinson, Paul A. Ramsland, Darren R. Jones, Mark Agostino, Maria E. Lund, Cameron V. Jennings, Vanessa Bockhorni, Elizabeth Yuriev, Allen B. Edmundson, Robert L. Raison, "Free Ig Light Chains Interact with Sphingomyelin and Are Found on the Surface of Myeloma Plasma Cells in an Aggregated Form", The Journal of Immunology, Williams & Wilkins Co., US, US , (20101001), vol. 185, no. 7, doi:10.4049/jimmunol.1001956, ISSN 0022-1767, pages 4179 - 4188, XP055616142
OPPOSITION- Peter-Christian Klöhn, Wuellner Ulrich, Zizlsperger Nora, Zhou Yu, Tavares Daniel, Berger Sven, Zettlitz Kirstin A., Proetzel Gabriele, Yong May, Begent Richard H.J., Reichert Janice M., "IBC's 23nd Annual Antibody Engineering, 10th Annual Antibody Therapeutics International Conferences and the 2012 Annual Meeting of The Antibody Society: December 3–6, 2012, San Diego, CA", mAbs, (20130301), vol. 5, no. 2, doi:10.4161/mabs.23655, ISSN 19420862, pages 178 - 201, XP055070468
SEARCH- PRESTA ET AL, "Engineering of therapeutic antibodies to minimize immunogenicity and optimize function", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, vol. 58, no. 5-6, ISSN 0169-409X, (20060807), pages 640 - 656, (20060807), XP024892146 [A] 1-26
SEARCH- DE KRUIF JOHN ET AL, "Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.", JOURNAL OF MOLECULAR BIOLOGY 3 APR 2009, (20090403), vol. 387, no. 3, ISSN 1089-8638, pages 548 - 558, XP002556330 [AP] 1
SEARCH- PELANDA R ET AL, "A prematurely expressed Ig(kappa) transgene, but not V(kappa)J(kappa) gene segment targeted into the Ig(kappa) locus, can rescue B cell development in lambda5-deficient mice.", IMMUNITY SEP 1996, (199609), vol. 5, no. 3, ISSN 1074-7613, pages 229 - 239, XP002556633 [A] 1-26 * figure 1 *
SEARCH- LONBERG NILS, "Human antibodies from transgenic animals", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20050901), vol. 23, no. 9, ISSN 1087-0156, pages 1117 - 1125, XP002442149 [AD] 1-26 * the whole document *
SEARCH- JAKOBOVITS AYA ET AL, "From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice.", NATURE BIOTECHNOLOGY OCT 2007, (200710), vol. 25, no. 10, ISSN 1087-0156, pages 1134 - 1143, XP002556637 [A] 1-26
SEARCH- WEINER LOUIS M, "Fully human therapeutic monoclonal antibodies", JOURNAL OF IMMUNOTHERAPY, LIPPINCOTT WILLIAMS & WILKINS, HAGERSTOWN, MD, US, (20060101), vol. 29, no. 1, ISSN 1524-9557, pages 1 - 9, XP009118693 [A] 1-26
SEARCH- SIRAC C ET AL, "Role of the monoclonal k chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, (20060715), vol. 108, no. 2, doi:10.1182/BLOOD-2005-11-4419, ISSN 0006-4971, pages 536 - 543, XP003030514 [A] 1-26

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents